Discover trends, market shifts, and competitive outlooks for the cell banking outsourcing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Cell Banking Outsourcing Market Size from 2025 to 2034?

In the past few years, there has been a surge in the size of the cell banking outsourcing market. This market is estimated to expand from $11.19 billion in 2024 to $12.89 billion in 2025, with a compound annual growth rate (CAGR) of 15.2%. Factors such as the escalating prevalence of chronic diseases, an uptick in government efforts, regulatory backing and guidelines, as well as the growth of banking services, have all contributed to this historic period growth.

In the coming years, the market size for cell banking outsourcing is projected to experience speedy growth. By 2029, the market is predicted to grow to $22.39 billion, with a compound annual growth rate (CAGR) of 14.8%. The forecast period’s growth can be credited to factors such as the increasing acceptance of cellular products, escalating demand for monoclonal antibodies, burgeoning adoption of stem cell therapies, an aging population, and a growing reliance on cell-based therapies. Notable trends for the forecast period encompass product innovations, technological progress, investment in research and development, and partnerships between biotech firms and specialized cell banking services.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Cell Banking Outsourcing Market?

The escalation in chronic disease prevalence is anticipated to drive the cell banking outsourcing market’s expansion. Chronic ailments are enduring conditions that usually evolve slowly and carry on for a prolonged duration. The surge in such conditions is attributed to various factors like lifestyle alterations, aging demographics, and genetic propensities. Cell banking outsourcing proves critical in enhancing research and development initiatives aimed at combating chronic diseases by offering expertise, resources, and infrastructure not typically available internally. For example, in July 2023, the Department of the Treasury, an Australian national treasury and financial department, stated that in 2020-2021, almost half of all Australians (46.6%) suffered from one or more chronic ailments, while nearly one in five (18.6%) had two or more chronic conditions. As a result, the increasing burden of chronic diseases is fueling the growth of the cell banking outsourcing market.

Which Key Market Segments Comprise the Cell Banking Outsourcing Market and Drive Its Revenue Growth?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

Which Areas Are Leading Regions in the Cell Banking Outsourcing Market Expansion Across the Globe?

North America was the largest region in the cell banking outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Technological Trends Are Reshaping the Cell Banking Outsourcing Industry Dynamics?

Companies that dominate the cell banking outsourcing market are prioritizing the creation of technologically superior solutions, like platforms for single-cell potency characterization, to conduct precise evaluations of the potency of individual cells. A platform for single-cell potency characterization is a complex technology or system of methodologies targeted at assessing the potency and functional abilities of cells within a population. One example is the January 2024 launch of VivaCyte by Cellply Srl, an Italian biotechnology firm. VivaCyte is the company’s key product and a comprehensive single-cell potency characterization platform that merges potency analysis with immunophenotyping to simplify cell therapy research and development. As a fully automated standalone platform, VivaCyte is designed to decrease development durations, costs, and risks through swift and comprehensive characterization of the intricate functionality of potential cellular immunotherapies. The platform expedites the testing of multiple cell therapy candidates against various target tumor cells, offering consistent immune cell characterization and functional characterization at the single-cell level in a time significantly less than that required by currently available analytical tools.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

How Is the Cell Banking Outsourcing Market Conceptually Defined?

Cell banking outsourcing refers to the practice of contracting external organizations to establish, maintain, and manage repositories of cell lines crucial for various applications in biotechnology and pharmaceutical industries, such as drug discovery and biomanufacturing. It ensures that cells are handled, stored, and maintained under standardized conditions, ensuring consistency and reliability.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15754

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model